Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Rare Trials You Can Trust: Biostatistics

  • Read more about Rare Trials You Can Trust: Biostatistics

Key Considerations when Conducting Rare Disease Paediatric Trials

  • Read more about Key Considerations when Conducting Rare Disease Paediatric Trials

Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial

Go back to Resources

Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Novel stem cell therapy to treat central retinal vein occlusion

Go back to Newsroom

Novel stem cell therapy to treat central retinal vein occlusion

Go back to Newsroom

Development of cerebral lateralization in children exposed to fetal antiseizure medications: A prospective cohort study at age 6 years

Go back to Resources

Development of cerebral lateralization in children exposed to fetal antiseizure medications: A prospective cohort study at age 6 years

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity

Go back to Resources

Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Interaction of identity and beliefs with genetic literacy

Go back to Resources

Interaction of identity and beliefs with genetic literacy

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel

Go back to Resources

Mental health challenges associated with sickle cell disease and strategies to address them: Reflections from a community input panel

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia

Go back to Newsroom

FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia

Go back to Newsroom

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature

Go back to Resources

The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature

Authors:

Volume:

Pagination:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification